Tibet Pharmaceuticals Exec Escapes Class Action Over IPO - Law360 (subscription)

Tibet Pharmaceuticals Exec Escapes Class Action Over IPO Law360 (subscription) Law360, New York (April 3, 2017, 1:19 PM EDT) -- A New Jersey federal judge has allowed a director of a Tibetan pharmaceutical company to escape an investor class action alleging the company lied about its financial health ahead of a 2011 initial ...

http://ift.tt/2ovHPqt